MELD and other predictors of survival after liver transplantation

:  Background:  This study examined how reliable is the pre‐transplant model for end‐stage liver disease (MELD) score in predicting post‐transplantation survival and analyzed variables associated with patient survival. Methods:  A cohort study was conducted. Receiver operating characteristic curve c...

Full description

Saved in:
Bibliographic Details
Published inClinical transplantation Vol. 23; no. 2; pp. 220 - 227
Main Authors Brandão, Ajacio, Fuchs, Sandra C., Gleisner, Ana L., Marroni, C., Zanotelli, Maria L., Cantisani, Guido
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.03.2009
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary::  Background:  This study examined how reliable is the pre‐transplant model for end‐stage liver disease (MELD) score in predicting post‐transplantation survival and analyzed variables associated with patient survival. Methods:  A cohort study was conducted. Receiver operating characteristic curve c‐statistics were used to determine the ability of MELD score to predict mortality. The Kaplan–Meier (KM) method was used to analyze survival as a function of time regarding the MELD score and Child‐Turcotte‐Pugh (CTP) category. The Cox model was employed to assess the association between baseline risk factors and mortality. Results:  Recipients and donors were mostly male, with a mean age of 51.6 and 38.5 yr, respectively (n = 436 transplants). The c‐statistic values for three‐month patient mortality were 0.60 and 0.61 for MELD score and CTP category, respectively. KM survival at three, six and 12 months were lower in those who had a MELD score ≥21 or were CTP category C. Multivariate analysis revealed that recipient age ≥65 yr, MELD ≥ 21, CTP C category, bilirubin ≥ 7 mg/dL, creatinine ≥ 1.5 mg/dL, platelet transfusion, hepatocellular carcinoma, and non‐white color donor skin were predictors of mortality. Conclusions:  Severe pre‐transplant liver disease, age ≥ 65, non‐white skin donor, and hepatocellular carcinoma are associated with poor outcome.
Bibliography:istex:2DD4A812CCB4B9927AD461B7BF93F30766DD728D
ark:/67375/WNG-RF20V5SS-W
ArticleID:CTR943
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0902-0063
1399-0012
DOI:10.1111/j.1399-0012.2008.00943.x